UK Approves Oxford-AstraZeneca Covid Vaccine
The UK government has issued emergency use authorization for the Covid-19 vaccine jointly developed by the pharmaceutical company AstraZeneca and researchers from Oxford University, two institutions notably based right there in the UK. The approval was announced by AstraZeneca on Wednesday.
The approval for AstraZeneca’s vaccine makes it the third pharmaceutical company to gain authorization from the UK government to distribute Covid-19 vaccines, after the American companies Pfizer and Moderna.
With AstraZeneca and Oxford University both based in the UK, the country will likely benefit more from their Covid-19 vaccine thanks to proximity, wherein AstraZeneca has committed to supply up to 100 million doses in the country.
AstraZeneca conducted trials for its vaccine and posted an efficacy rate of 70% from its trials last month. The company has now been authorized to distribute vaccines to be administered on individuals 18 years or older, with a recommended two-shot dosage to be administered in an interval of between 4 and 12 weeks.
Even as it’s gotten emergency authorization, AstraZeneca will continue its trials for its Covid-19 vaccine across the globe. The company says it’s setting up manufacturing capacity to produce up to 3 billion doses of its vaccine next year.